Decreased renal clearance due to renal dysfunction [41], in addition to higher synthesis in the liver, thymus, spleen, and bone due to non-classic regulators of FGF23 production (PTH, vitamin D, and phosphate), would explain the acute increase in plasma FGF23 in AKI [20,21]. The gene discussed is FGF23; the disease is Abnormal renal physiology.